WTH Panel 🎤 Funding the Future: Investment & Market Trends in Healthtech 💰

​🎤 Panel discussion + audience Q&A

​Want to get the inside scoop on the current investment landscape in healthtech? Join us for an insightful panel discussion with industry leaders as we dive into the latest trends, opportunities, and challenges shaping the future of healthtech investments.

​💡 What to expect:

• ​What investors look for in healthtech companies

• ​How they evaluate opportunities and make funding decisions

• ​The impact of emerging technologies on investment strategies

• ​The current trends and market dynamics in the industry

• ​What excites investors about the future of healthtech

​Of course, there’ll be plenty of time for audience questions!

​📣 Speaker lineup:

• ​Adele Moynihan (Bupa Ventures) – Part of the team that established Bupa Ventures, Bupa's early-stage investment arm here to accelerate health techs and provide them access to the corporate's strategic assets. Prior, a founding member of early-stage VC, Antler Australia where Adele built and executed the fund's GTM, was part of the leadership team and sat as an investment committee voting member. Having worked across all functions of the VC firm she is versed in fund set-up, deal sourcing, leading investment processes, and raising early-stage capital.
  

• ​Adam Milgrom (Partner, Giant Leap) – Adam is a highly proficient strategist with over 10 years experience across a range of industries. He is an active investor in early stage Australian and International businesses. Adam is committed to making a positive impact and has combined his interest in technology with the desire to work on projects which accelerate us towards a better future.
  

• ​Aizaz Syed (Investment & Portfolio Manager, Tenmile) – Aizaz leads investments and portfolio strategy at Tenmile, a health technology investment firm owned by Tattarang. He is currently also a non-executive director of Aravax Pty Ltd, which is developing a novel immunotherapy for treatment against peanut allergies, and Proton Intelligence Inc. a med-tech startup developing the world’s first continuous at home potassium monitoring sensor for patients with chronic kidney disease and heart failure. Aizaz has spent the last 10 years investing in early-stage technologies, strategy, financial and commercial advisory roles.

​See you there! ✨